Suggested Approaches for Minimizing Background Chemical Noise in Low Mass MRM Transitions for Trace Level Quantification of N-Nitrosamines

Significance of the Topic

The identification and quantification of N-nitrosamines in pharmaceuticals is essential for patient safety and regulatory compliance. This application note focuses on minimizing background chemical noise in low mass MRM transitions to achieve reliable trace level detection.

Study Objectives and Overview

This study aims to optimize LC-MS/MS conditions for ultra-trace quantitation of seven N-nitrosamine impurities using UPLC with APCI source and tandem quadrupole mass spectrometry. Key goals include reducing background noise in critical MRM channels and establishing sensitivity parameters.

Methodology and Used Instrumentation

Optimization strategies included

• Adjustment of APCI cone gas flow rate to reduce solvent clusters and interfering ions
• Tuning of cone voltage per MRM transition to maximize signal to noise
• Selection of high purity mobile phases and solvent brands to avoid chemical noise

Instrumentation:

• ACQUITY Premier UPLC System
• Xevo TQ Absolute Tandem Quadrupole Mass Spectrometer
• MassLynx Mass Spectrometry Software
• TargetLynx Data Processing Software

Main Results and Discussion

Optimization identified an APCI cone gas flow of 350 L/hr and a cone voltage of 50 V for the NDMA confirmatory MRM channel as optimal for minimizing baseline noise. Comparison of LC-MS grade methanol sources revealed one brand provided significantly lower background. The method achieved limits of detection between 0.01 and 0.50 ng/mL and limits of quantitation between 0.02 and 1.0 ng/mL for the seven nitrosamines, with linear calibration ranges up to 100 ng/mL and correlation coefficients above 0.99.

Practical Benefits and Applications

Key advantages of the optimized method include:

• Enhanced confidence in nitrosamine identification through multiple confirmatory ions
• Improved signal to noise facilitating quantitation at or below regulatory threshold levels
• Broad applicability to pharmaceutical QA/QC for new and marketed products

Future Trends and Applications

Potential developments include:

• Integration of automated sample cleanup techniques
• Application of machine learning for noise pattern recognition and parameter optimization
• Deployment of novel stationary phases to further improve chromatographic separation of isobaric compounds
• Extension of the approach to emerging nitrosamine analogues and other trace level contaminants

Conclusion

Effective background noise management across the entire LC-MS/MS workflow is vital for reliable trace level quantitation of N-nitrosamines. By optimizing APCI parameters and selecting high purity reagents, the method delivers robust sensitivity and selectivity, supporting compliance with stringent regulatory limits.

Reference

1. Moser et al. Journal of Pharmaceutical Sciences 112(5):1161–1162 (2023)
2. Teasdale et al. Mutagenic Impurities, Wiley (2021)
3. Bharate SS. Journal of Medicinal Chemistry 64(6):2923–2936 (2021)
4. Lame & Hatch. Waters Application Note 720006899 (2020)
5. Maziarz et al. Waters Application Note 720007725 (2022)
6. Chang et al. Journal of Pharmaceutical and Biomedical Analysis 221:115003 (2022)
7. Wichitnithad et al. Talanta 254:124102 (2023)
8. David et al. Mutagenic Impurities, Wiley (2021)
9. Zhao et al. Environmental Science & Technology 40(24):7636–7641 (2006)
10. Nagendla et al. Journal of Chromatography Open 2:100053 (2022)
11. Lee et al. Int J Environ Anal Chem 93(12):1261–1273 (2013)
12. Ripollés et al. Analytica Chimica Acta 702(1):62–71 (2011)